WHO To Conduct Full Review Of Data On Revised Guidance For The Use Of  Dengvaxia, Philippines Ordered A Probe Following An Announcement By Sanofi Saying The Drug Could Worsen Disease In Some Cases, Co. Says Most Doses Were Sold In Philippines And Brazil